Ten chronic enteric typhoid carriers treated with oral ampicillin have been followed for 4 Ampicillin has been demonstrated to be an effective form of therapy in eradicating Salmonella typhi in 50 to 100% of chronic enteric typhoid carriers (1, (3) (4) (5) . Relapses most commonly occur in patients with cholelithiasis and usually within 3 months of discontinuing ampicillin therapy. Most patients are therefore followed for only 6 to be related to absence of cholelithiasis, courses of ampicillin of at least 6 weeks' duration, and shorter duration of carrier state in cured patients.
The present study was undertaken to provide long-term follow-up of chronic typhoid carriers apparently cured with ampicillin. Ten of the twelve patients originally reported as cured Three or more stool specimens were collected from each patient during the 12 months preceding the date of the last negative stool culture ( Table  1) . Specimens of stool were inoculated on eosin methylene blue and Salmonella-Shigella agar plates and in tetrathionate and Selenite-F Enrichment (BBL) Broth for isolation of salmonella as previously described (2) .
All ten patients continue to have negative stool cultures with periods of follow-up now ranging from 4 to 9 years (median 6.5 years). The total number of negative stool cultures per patient ranges from 12 to 34. The duration of ampicillin therapy was 6 weeks in all ten patients. Eight patients also received probenecid. Cholelithiasis was present in four patients. Only one of these four patients (CH) has had a cholecystectomy subsequently. The ten patients have now been followed from 4 to 9 years after ampicillin therapy, and no relapses have occurred. In our original report, all but three of the patients who were unsuccessfully treated relapsed within 90 days after discontinuation of ampicillin. One 
